Lantern Pharma (LTRN)

15.73 -0.32 (1.99%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (2/1/21 *Est.)

Latest Headlines

Form 10-Q Lantern Pharma Inc. For: Sep 30 October 29, 2020 4:01 PM - SEC Filing Form 8-K Lantern Pharma Inc. For: Oct 29 October 29, 2020 4:00 PM - SEC Filing Lantern Pharma Reports Third Quarter 2020 Financial Results & Continued Operational Progress October 29, 2020 3:59 PM - PR NewsWire Lantern Pharma to Host Third Quarter 2020 Operating and Financial Results Conference Call on October 29, 2020 at 4:00 p.m. ET October 22, 2020 7:00 AM - PR NewsWire Form SEC STAFF LETTER Lantern Pharma Inc. October 13, 2020 1:32 PM - SEC Filing Form SEC STAFF LETTER Lantern Pharma Inc. October 13, 2020 1:31 PM - SEC Filing Lantern Pharma (LTRN) Reports Advancement of Prostate Cancer Drug Development Research Collaboration with Georgetown University for LP-184 October 5, 2020 7:59 AM - StreetInsider Lantern Pharma Advances Prostate Cancer Drug Development Research Collaboration with Georgetown University for LP-184, a Next-Generation, Targeted DNA-Damaging Agent October 5, 2020 7:46 AM - PR NewsWire Lantern Pharma (LTRN) Announces Pact with Fox Chase Cancer Center Focused on Advancing Development of LP-184 in Pancreatic Cancer September 22, 2020 7:56 AM - StreetInsider Lantern Pharma Announces Collaboration and Research Agreement with Fox Chase Cancer Center Focused on Advancing the Development of LP-184 in Pancreatic Cancer September 22, 2020 7:55 AM - PR NewsWire Lantern Pharma Announces Upcoming Conference Presentations August 27, 2020 7:55 AM - PR NewsWire Full Article List